These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 22321707)

  • 1. [Effects of rosiglitazone on peroxisome proliferator activated receptor-γ pathway in patients with chronic obstructive pulmonary disease].
    Zeng XL; Liu XJ; Bao HR; Zhang Y; Tan EL; Liao JM
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Oct; 34(10):743-8. PubMed ID: 22321707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An experimental study on the reverse mechanism of PPAR-gamma agonist rosiglitazone in rats with non-alcoholic steatohepatitis].
    Zhao CY; Wang YD; Zhou JY; Jia B; Cui JF
    Zhonghua Gan Zang Bing Za Zhi; 2007 Jun; 15(6):450-5. PubMed ID: 17594812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The protective effects and mechanisms of peroxisome proliferator-activated receptor-gamma agonist in rats with acute lung injury].
    Wang JC; Jiang P; Huang J; Qian GS
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jun; 31(6):425-30. PubMed ID: 19031802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of peroxisome proliferator-activated receptor-γ/nuclear factor-ΚB transduction pathway on coagulation disorders induced by sepsis].
    Sun Y; Wang J; Yu L; Dai L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Jun; 27(6):520-4. PubMed ID: 26049195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, Attenuates Inflammation Via NF-κB Inhibition in Lipopolysaccharide-Induced Peritonitis.
    Zhang YF; Zou XL; Wu J; Yu XQ; Yang X
    Inflammation; 2015 Dec; 38(6):2105-15. PubMed ID: 26047949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classical NF-κB activation impairs skeletal muscle oxidative phenotype by reducing IKK-α expression.
    Remels AH; Gosker HR; Langen RC; Polkey M; Sliwinski P; Galdiz J; van den Borst B; Pansters NA; Schols AM
    Biochim Biophys Acta; 2014 Feb; 1842(2):175-85. PubMed ID: 24215713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of PPAR-gamma agonist rosiglitazone on MMP-9 and TIMP-1 expression of monocyte-derived macrophages isolated from patients with acute coronary syndrome].
    Luo YM; Wan XH; Jiang DQ; Kuang WY; Guo HB; Chen ZX; Wang HJ; Xie LH; Duan W
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Aug; 37(8):739-45. PubMed ID: 20021931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosstalk between peroxisome proliferator-activated receptor-γ and mineralcorticoid receptor in TNF-α activated renal tubular cell.
    Xiao J; Chen W; Lu Y; Zhang X; Fu C; Yan Z; Zhang Z; Ye Z
    Inflamm Res; 2015 Aug; 64(8):603-14. PubMed ID: 26072064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trans-10, cis-12 conjugated linoleic acid and the PPAR-γ agonist rosiglitazone attenuate lipopolysaccharide-induced TNF-α production by bovine immune cells.
    Perdomo MC; Santos JE; Badinga L
    Domest Anim Endocrinol; 2011 Oct; 41(3):118-25. PubMed ID: 21798687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulated peroxisome proliferator-activated receptor γ (PPARγ) in lung epithelial cells promotes a PPARγ agonist-reversible proinflammatory phenotype in chronic obstructive pulmonary disease (COPD).
    Lakshmi SP; Reddy AT; Zhang Y; Sciurba FC; Mallampalli RK; Duncan SR; Reddy RC
    J Biol Chem; 2014 Mar; 289(10):6383-6393. PubMed ID: 24368768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia.
    Liu D; Zeng BX; Zhang SH; Yao SL
    Inflamm Res; 2005 Nov; 54(11):464-70. PubMed ID: 16307220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of rosiglitazone on lipopolysaccharide-induced inflammation in a murine model and HK-2 cells.
    Wang WM; Chen H; Zhong F; Lu Y; Han L; Chen N
    Am J Nephrol; 2011; 34(2):152-62. PubMed ID: 21734368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proinflammatory stimulation and pioglitazone treatment regulate peroxisome proliferator-activated receptor gamma levels in peripheral blood mononuclear cells from healthy controls and multiple sclerosis patients.
    Klotz L; Schmidt M; Giese T; Sastre M; Knolle P; Klockgether T; Heneka MT
    J Immunol; 2005 Oct; 175(8):4948-55. PubMed ID: 16210596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats.
    Liu DS; Liu WJ; Chen L; Ou XM; Wang T; Feng YL; Zhang SF; Xu D; Chen YJ; Wen FQ
    Toxicology; 2009 Jun; 260(1-3):112-9. PubMed ID: 19464576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor-gamma ligand reduced tumor necrosis factor-alpha-induced interleukin-8 production and growth in endometriotic stromal cells.
    Ohama Y; Harada T; Iwabe T; Taniguchi F; Takenaka Y; Terakawa N
    Fertil Steril; 2008 Feb; 89(2):311-7. PubMed ID: 17555752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of nuclear factor-kappaB on peroxisome proliferator activated receptor gamma expression in Ana-1 cells].
    Xiao B; Wang JC; Wang GS; Ji FY; Xu J
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jan; 21(1):3-7. PubMed ID: 19141181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The proteasome inhibitor MG132 attenuates skeletal muscle atrophy in a rat model of chronic obstructive pulmonary disease].
    Ma BM; Liu ZH; Liang ZK; Guan LJ; Wang XL
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jun; 36(6):441-6. PubMed ID: 24103208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of peroxisome proliferator-activated receptor-γ ligands on in vitro and in vivo models of COPD.
    Lea S; Plumb J; Metcalfe H; Spicer D; Woodman P; Fox JC; Singh D
    Eur Respir J; 2014 Feb; 43(2):409-20. PubMed ID: 23794466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of sulforaphane on Toll-like receptor 4/myeloid differentiation factor 88 pathway of monocyte-derived macrophages from patients with chronic obstructive pulmonary disease].
    Zeng X; Liu X; Bao H; Zhang Y; Wang X; Shi K; Pang Q
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Apr; 37(4):250-4. PubMed ID: 24969711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosiglitazone decreases peroxisome proliferator receptor-γ levels in microglia and inhibits TNF-α production: new evidences on neuroprotection in a progressive Parkinson's disease model.
    Carta AR; Frau L; Pisanu A; Wardas J; Spiga S; Carboni E
    Neuroscience; 2011 Oct; 194():250-61. PubMed ID: 21839812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.